NSIM
RMD icon

North Star Investment Management’s ResMed RMD Stock Holding History

North Star Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.92K Buy
13
+4
+44% +$997 ﹤0.01% 1342
2025
Q4 		$2.17K Buy
+9
New +$2.3K ﹤0.01% 1318
2023
Q4 		– Sell
-5
Closed -$739 – 1273
2023
Q3 		$739 Hold
5
– – ﹤0.01% 1167
2023
Q2 		$1.09K Hold
5
– – ﹤0.01% 1147
2023
Q1 		$1.09K Hold
5
– – ﹤0.01% 1154
2022
Q4 		$1.04K Buy
+5
New +$1.1K ﹤0.01% 1156

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

North Star Investment Management's RMD Position: Q1 2026 in Review

North Star Investment Management increased its ResMed (RMD) stake by 44% in Q1 2026, buying an estimated $997 and bringing the position to 13 shares worth $2.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1342.

North Star Investment Management first reported a position in RMD in Q4 2022 and has held it in 6 quarters since. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • North Star Investment Management held 13 shares of ResMed worth $2.92K as of Q1 2026.
  • North Star Investment Management bought 4 ResMed shares in Q1 2026, an estimated $997.
  • ResMed made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #1342 holding.
  • North Star Investment Management first reported a position in ResMed in Q4 2022 and has held it in 6 quarters since.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.